-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

632. Chronic Myeloid Leukemia: Clinical and Epidemiological: Poster III

Symposia: Chronic Myeloid Leukemia: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Monday, December 11, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Alessandra Iurlo, MD, PhD1*, Massimo Breccia2*, Fabio Stagno, MD, PhD3, Elisabetta Abruzzese, MD4, Fabrizio Pane, MD5, Immacolata Attolico, MD6*, Paolo Sportoletti, MD7*, Marco Cerrano, MD8*, Sara Galimberti, MD, PhD9*, Barbara Scappini10*, Maurizio Miglino, MD, PhD11*, Sergio Siragusa12*, Isabella Capodanno, MD13*, Diletta Valsecchi14*, Aurelio Pio Nardozza14*, Alessandra Misto14*, Paola Coco14*, Giuseppe Saglio, MD15 and Gianantonio Rosti, MD16*

1Hematology Division, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
2Department of Translational and Precision Medicine, Hematology-Sapienza University, Rome, Italy
3Division of Hematology and Bone Marrow Transplant, AOU Policlinico “Rodolico – San Marco”, Catania, Italy
4Department of Hematology, S Eugenio Hospital, Tor Vergata University, Roma, I, Italy
5Dipartimento Medicina Clinica e Chirurgia, UOC Ematologia e Trapianti di Midollo, Azienda Ospedaliera Universita Federico II, Napoli, Italy
6University of Bari, Department of Emergency and Organ Transplantation (D.E.T.O.), Hematology Section, Bari, Bari, Italy
7Centro di Ricerca Emato-Oncologica (CREO), Dipartimento di Medicina e Chirurgia, University of Perugia, Perugia, Italy
8Hematology Unit, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Turin, Turin, Italy
9Department of Clinical and Experimental Medicine, Hematology, University of Pisa, Pisa, Italy
10SOD Ematologia, Università di Firenze, AOU Careggi, Firenze, Italy
11Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Genoa, Italy
12Department PRO.MI.SE, University of Palermo, Palermo, Palermo, Italy
13Hematology Department, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, Reggio Emilia, Italy
14Novartis Farma SpA, Milano, Milano, Italy
15Dept. of Clinical and Biological Sciences, University of Turin, Turin, Italy
16Medical Oncology Unit, IRST/IRCCS “Dino Amadori,”, Meldola (FC), Italy

Rüdiger Hehlmann, MD 1, Michael Lauseker, PhD2*, Andreas Hochhaus, MD3 and Susanne Saussele, MD 4

1ELN-Foundation, Weinheim, Germany
2IBE Munich University, Munich, Germany
3Universitätsklinikum Jena, Jena, Germany
4Heidelberg University Medical Faculty Mannheim, Mannheim, DEU

Michael Mauro, MD1, Yosuke Minami, MD, PhD2, Andreas Hochhaus, MD3, Elza Lomaia, MD, PhD4*, Sergei Voloshin, MD5*, Anna Turkina, MD6*, Dong-Wook Kim, MD, PhD7, Jane F Apperley, FRCP, FRCPath, MB8, Jorge Cortes, MD9, Andre N.R. Abdo, MD10*, Laura Maria Fogliatto, MD11*, Dennis Dong Hwan Kim12*, Philipp le Coutre, MD13*, Susanne Saussele, MD 14, Mario Annunziata, MD15*, Timothy P Hughes, MD, MBBS, FRACP, FRCPA16, Naeem A. Chaudhri, MD17, Lynette C.Y. Chee, MBBS, PhD, FRACP, FRCPA18, Valentín García Gutiérrez, PhD19, Koji Sasaki, MD20, Carla Maria Boquimpani De Moura Freitas, MD21*, Shruti Kapoor, MS22*, Noemi Espurz, MS23*, Vishal Dhamal24* and Delphine Rea, MD, PhD25

1Memorial Sloan Kettering Cancer Center, New York, NY
2National Cancer Center Hospital East, Kashiwa, Japan
3Universitätsklinikum Jena, Jena, Germany
4Almazov National Medical Research Centre, St. Petersburg, Russian Federation
5Russian Scientific and Research Institute of Hematology and Transfusiology, St Petersburg, Russian Federation
6National Medical Research Center for Hematology, Moscow, Russian Federation
7Uijeongbu Eulji Medical Center, Uijeoungbu-si, Korea, Republic of (South)
8Centre for Haematology, Imperial College London, London, United Kingdom
9Georgia Cancer Center, Augusta University, Augusta, GA
10Instituto do Câncer do Estado de São Paulo (ICESPSP), São Paulo, Brazil
11Hospital das Clínicas de Porto Alegre. Porto Alegre, Rio Grande do Sul – Brazil, Porto Alegre, Brazil
12Princess Margaret Cancer Centre / University Health Network, Toronto, ON, Canada
13Charité-Universitätsmedizin Berlin, Berlin, Germany
14III. Medizinische Klinik, Medizinische Fakultät Mannheim der Universität Heidelberg, Mannheim, Germany
15Division of Hematology, AORN Cardarelli, Naples, Italy
16South Australian Health and Medical Research Institute (SAHMRI), Adelaide, SA, Australia
17Dept of Hematology, Stem Cell Transplantation and Cellular Therapy , KFSHRC, Riyadh, Saudi Arabia
18Department of Clinical Haematology and Bone Marrow Transplant Service, The Royal Melbourne Hospital, Parkville, Australia
19Servicio de Hematología, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain
20Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
21HEMORIO, State Institute of Hematology Arthur de Siquiera Cavalcanti, RIO DE JANEIRO/RJ, Brazil
22Novartis Pharmaceuticals Corporation, East Hanover, NJ
23Novartis Pharma AG, Basel, Switzerland
24Novartis Healthcare Private Limited, Hyderabad, India
25Hematology Department, Hôpital Saint-Louis, Paris, France

Naoto Takahashi, M.D., Ph.D.1, Takeshi Kondo, MD, PhD2, Yuji Ikari3*, Yoshihiro Fukumoto4*, Kiyohiko Hatake, MD, PhD5, Akira Masunari6*, Seiji Nishibayashi7*, Akiko Kageyama8*, Yasuhiko Fukuta7* and Arinobu Tojo9*

1Department of Hematology, Nephrology and Rheumatology, Akita University, Akita, Japan
2Blood Disorders Center, Aiiku Hospital, Sapporo, Japan
3Department of Cardiology, Tokai University School of Medicine, Isehara, Japan
4Division of Cardiovascular Medicine, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Japan
5International University of Health and Welfare, Tokyo, JPN
6Pharmacovigilance, Otsuka Pharmaceutical Co., Ltd,, Osaka, Japan
7Pharmacovigilance, Otsuka Pharmaceutical Co., Ltd, Osaka, Japan
8Medical Affairs, Otsuka Pharmaceutical Co., Ltd, Tokyo, Japan
9Institute of Innovation, Tokyo Medical and Dental University, Tokyo, Japan

Ziyu Wen1*, Zhiping Fan2*, Qiang Wang, MD2*, Xuan Zhou2*, Zherou He, MBBS2*, Zicheng Gao2*, Hong Chen2*, Hanyin Liang2*, Dongmei Luo2*, Xiaoli Liu2*, Hongsheng Zhou2*, Qifa Liu, MD3 and Na Xu2*

1Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, AL, China
2Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China
3Nanfang Hospital, Southern Medical University, Guangzhou, China

Katharina Kohlbrenner1*, Norbert Galuschek1*, Alice Fabarius1*, Marcel Reiser2*, Klaus Fenchel3*, Eva Esseling, MD4*, Thomas Göhler5*, Ralf-Bodo Kühn6*, Reinhard Depenbusch7*, Ivo Talah Azeh8*, Erik Engel9*, Richard Hansen10*, Mathias Hanel, MD11, Paul Jehner12*, Maisun Abu-Samra13*, Markus Ritter14*, Norbert Gattermann, MD15, Henning Pelz16*, Stefan Fuxius17*, Burkhard Oswald18*, Gabriela M Baerlocher, MD19,20*, Tim H. Brümmendorf21,22, Dominik Heim23*, Philipp le Coutre, MD24*, Andreas Burchert, MD25, Dietger Niederwieser, MD, PhD26*, Hans Tesch, MD27*, Wolf-Karsten Hofmann, MD1*, Andreas Hochhaus, MD28, Rüdiger Hehlmann, MD 29,30 and Susanne Saussele, MD 1

1Medizinische Fakultät Mannheim, III. Medizinische Universitätsklinik, Universität Heidelberg, Mannheim, Germany
2Praxis für internistische Onkologie und Hämatologie (PIOH), Frechen, Germany
3Schwerpunktpraxis für Onkologie und Hämostaseologie, MVZ Saaletal, Saalfeld, Germany
4Medizinische Klinik A, Universitätsklinikum Münster, Münster, Germany
5Onkozentrum Dresden/Freiberg/Meißen, Dresden, Germany
6Onkologische Praxis Oldenburg/Delmenhorst, Oldenburg, Germany
7Onkologische Gemeinschaftspraxis Dres. Depenbusch, Schütt und Sonnenberg, Gütersloh, Germany
8Onkologische Gemeinschaftspraxis und Tagesklinik Dres. Schardt & Azeh, Gelsenkirchen, Germany
9Hämatologisch-Onkologische Praxis Altona (HOPA), Hamburg, Germany
10Onkologische Gemeinschaftspraxis Dres . Hansen und Reeb, Kaiserslautern, Germany
11Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany
12Onkologische Praxis Moers, Moers, Germany
13Medizinische Klinik IV und Poliklinik für Hämatologie, Universitätsklinikum Gießen und Marburg, Campus Gießen, Gießen, Germany
14Klinik für Innere Medizin - Hämatologie / Onkologie, Klinikum Sindelfingen-Böblingen, Sindelfingen, Germany
15Klinik für Hämatologie, Onkologie und Klinische Immunologie, Universitätsklinikum Düsseldorf, Düsseldorf, Germany
16Onkologie Offenburg, Offenburg, Germany
17Onkologische Schwerpunktpraxis Heidelberg, Heidelberg, Germany
18Onkologische Schwerpunktpraxis Worms, Worms, Germany
19Universitätsklinik für Hämatologie, Inselspital Bern, Bern, Switzerland
20Department for BioMedical Research (DBMR), Laboratory for Hematopoiesis and Molecular Genetics, Universität Bern, Bern, Switzerland
21Medizinische Klinik IV, Universitätsklinikum RWTH Aachen, Aachen, Germany
22Center for Integrated Oncology, Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany
23Klinik für Hämatologie, Universitätsspital Basel, Basel, Germany
24Charité-Universitätsmedizin Berlin, Berlin, Germany
25Hämatologie, Onkologie und Immunologie, Universitätsklinikum Gießen und Marburg, Standort Marburg, Marburg,, Germany
26Abteilung Hämatologie und lnternistische Onkologie, Universitätsklinikum Leipzig, Lepzig, Germany
27Centrum für Hämatologie und Onkologie Bethanien, Frankfurt am Main, Germany
28Klinik für Innere Medizin II, Abt. Hämatologie und lnternistische Onkologie, Universitätsklinikum Jena, Jena, Germany
29Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany
30ELN Foundation, Weinheim, Germany

Hippolyte Guerineau, PharmD1*, Jean-Michel Cayuela, PharmD, PhD2,3*, Stéphanie Dulucq, PharmD, PhD3,4,5*, Violaine Tran Quang, PharmD1*, Sihem Tarfi, PharmD1*, Quentin Barathon6*, Corine Joy6*, Orianne Wagner-Ballon, MD, PhD1, Stéphane Morisset, Biostat3,7*, Franck E. Nicolini, MD, PhD3,8, Lydia Roy, MD3,9*, Sébastien Maury9*, Gabriel Etienne, MD, PhD3,10*, Delphine Rea, MD, PhD3,11 and Ivan Sloma, PhD, PharmD1,3*

1Hematology and Immunology Department, Henri Mondor University Hospital, UPEC, IMRB, Assistance Publique Hopitaux de Paris, Créteil, France
2University Hospital Saint-Louis, APHP and Paris DIDEROT, Paris, FRA
3Centre Léon Bérard, Fi-LMC, Lyon, France
4Laboratoire Hématopoïèse Leucémique Et Cible Th, Bordeaux Cedex, FRA
5Laboratory of Hematology, Hôpital Haut Lévêque, Centre Hospitalier Universitaire de Bordeaux, Pessac, France
6Hematology and Immunology Department, Henri Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, Créteil, France
7Centre Léon Bérard, Lyon, France
8Hematology department & CRCL INSERM U1052, Centre Léon Bérard, Lyon, France
9Hematology Department, Henri Mondor University Hospital, UPEC, IMRB, Assistance Publique Hopitaux de Paris, Créteil, France
10Hematology department, Institut Bergonié, Bordeaux, France
11Hematology Department, Hôpital Saint-Louis, Paris, France

Dragana Milojkovic, MD, PhD, FRCPath1*, Nicole Blijlevens, MD, PhD2*, Yok-Lam Kwong, MD3*, Uzma Zaidi, FCPS4*, Fausto Castagnetti, MD, PhD5,6, Paolo Gallipoli, MD7, Maria Cristina Miggiano, MD8*, Peter E Westerweel9*, Melissa Chen, MBBS10*, M. Carmen Garcia Hernandez11*, William J. Kell, MD12, Pankit Vachhani, MD13*, Neha Agarwal14*, Alessandra Colasante15*, Sridhar Meka16*, Aoife Smyth, PhD17*, Germano Ferreira18* and Jeroen J.W.M. Janssen, MD, PhD19

1Department of Haematology, Imperial College Healthcare NHS Trust, London, United Kingdom
2Department of Hematology, Radboud University medical center, Nijmegen, Gelderland, NLD
3Department of Medicine, The University of Hong Kong, Hong Kong, China
4Department of Clinical Hematology and Bone Marrow Transplant, National Institute of Blood Diseases and Bone Marrow Transplantation, Karachi, Pakistan
5University Hospital, University of Bologna, Bologna, Italy
6Institute of Hematology "L. e A. Seràgnoli", University of Bologna, Bologna, Italy
7Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom
8Hematology Department, San Bortolo Hospital, Vicenza, Italy
9Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, Netherlands
10Department of Haematology, Monash Health, Clayton, VIC, AUS
11Hematology Department, Hospital General Universitario de Alicante, Alicante, ESP
12University Hospital of Wales, Cardiff, GBR
13University of Alabama at Birmingham, Birmingham, AL
14Parexel International, Bengaluru, India
15Parexel International, Milan, Italy
16Parexel International Private Limited, Hyderabad, India
17Novartis Pharma AG, London, GBR
18Novartis Pharma AG, Basel, Switzerland
19Department of Hematology, Radboud University Medical Center, Nijmegen, Netherlands

Rajan Kapoor, DM1*, Laboni Sarkar2*, Aby Abraham, MD, DM3*, Akhil Rajendra, MD, MBBS, DM4*, Jina Bhattacharyya, MD5*, Kundan Mishra, MD, DM6*, Anu Korula, MD, DM7*, Dubashi Biswajit, MD, DNB, DM8*, Dr Nandini, MD9*, Sushil Selvarajan, MD, DM7*, Alok Shetty, MD, DM10*, Lingaraj Nayak, MBBS, MD, DM11*, Parathan Karunakaran12*, Damodar Das, MD, DNB5*, Rajeev Kumar, MD, DM13*, Jayachandran Perumal Kalaiyarasi, MD, MBBS, DM, MRCP14*, Smita Kayal, MD, DM15*, Gopa Kumar, MD9*, Priyanka Samal, MD, DM, MBBS16*, Sewali Deka Talukdar, MD17*, Hemani Jain18*, Rasmi Palassery, MD19*, Smitha Carol Saldanha, MD, DM, MBBS20*, Nikhil Patkar, MD21*, Uday Prakash Kulkarni, MD, MBBS22*, Mobin Paul, M.D, D.M23* and Vikram Mathews, MD24

1Clinical Hematology and Stem Cell Transplantation, Army Hospital Research and Referral, New Delhi, India
2TMH Mumabai, Mumbai, India
3Department of Hematology, Christian Medical College, Vellore, Ranipet, India
4CIA Chnnai, Chennai, Tamil Nadu, IND
5Guwahati Medical College, Guwahati, IND
6Command Hospital (CC), New Delhi, India
7Department of Haematology, Christian Medical College Vellore, Vellore, India
8Jawaharlal Inst. of Postgraduate Medical Edu & Res., Puducherry, IND
9MCC, Kerala, Kerla, India
10Department of Medical Oncology, Tata Memorial Centre, Mumbai, India
11Department of Medical Oncology, Tata Memorial Centre, MUMBAI, India
12CIA, Chennai, IND
13Army Hospital(Reserch & Referral), New Delhi, India
14Cancer Institute WIA, Chennai, India
15JIPMER, Puducherry, Puducherry, IND
16IHTM,MCH, KOLKATA, KOLKATA, WEST BENGAL, IND
17Guwahati Medical College, Guwahati, India
18Tata Memorial Centre, Mumbai, IND
19MS Ramaiah Medical College, Bengaluru, Karnataka, IND
20Kidwai Memorial Institute of Oncology, Bengaluru, India
21Department of Hemato Pathology, Tata Memorial Centre, Mumbai, India
22CMC, Vellore, Tamil Nadu, IND
23Department of Clinical Haematology & Hemato - Oncology, Rajagiri Hospital, Kochi, India
24Department of Haematology, Christian Medical College, Vellore, Ranipet, Tamil Nadu, India

Maria Agustina Perusini, MD1, Katia Pagnano, MD, PhD2*, Carolina Pavlovsky, MD3*, Beatriz Moiraghi, MD4*, Ana Varela, MD4*, Michele Bianchini5*, Carmen Fava, MD, PhD6*, Jiří Mayer, MD7, Daniela Žáčková, MD8*, Anežka Kvetková, MD8*, Tomáš Jurček, PhD8*, Ivana Ježíšková, PhD8*, Ana Beatriz Pascoal Lopes2*, Gislaine Borba Oliveira, MD, Msc2*, Carmino De Souza, MD, PhD2*, Amirthagowri Ambalavanan9*, Anthea Travas9*, Jaeyoon John Kim10*, Danielle Pyne9*, Jessie Medeiros9, Sagi Abelson11* and Dennis Dong Hwan Kim, MD, PhD12

1Princess Margaret Cancer Centre / University Health Network, Toronto, ON, Canada
2Hematology and Hemotherapy Center, University of Campinas, Campinas, Brazil
3FUNDALEU, Buenos Aires, Argentina
4Hospital Jose Maria Ramos Mejia, Buenos Aires, Argentina
5CIO-FUCA, Instituto Alexander Fleming, Buenos Aires, Argentina
6Department of Clinical and Biological Sciences, University of Turin, Torino, Italy, Orbassano, To, Italy
7University Hospital Brno and Masaryk University, Brno, Czech Republic
8Dpt. of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic
9University Health Network, Toronto, Canada
10Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
11University Health Network, Princess Margaret Cancer Centre, Toronto, Canada
12Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

Jitka Krizkova, PhD1*, Vaclava Polivkova, PhD1*, Nikola Curik, PhD1*, Adam Laznicka1*, Adela Benesova, PhD1*, Hana Klamova1*, Marketa Stastna Markova, MD, PhD1*, Dana Srbova1*, Jan Zuna, MD, PhD2, Marketa Zaliova, MD, PhD2*, Jan Trka, MD, PhD3, Pavel Semerak1*, Tomas Kalina, MD, PhD2*, Cyril Salek, MD, PhD1 and Katerina Machova Polakova1*

1Institute of Hematology and Blood Transfusion, Prague, Czech Republic
2CLIP, Department of Pediatric Hematology and Oncology, University Hospital Motol, Prague, Czech Republic
3Charles University, Prague, Prague, Czech Republic

Lisi Huang, M.D.1*, Suxia Geng, M.D., Ph.D.1*, Yulian Wang, M.D., Ph.D.1*, Zesheng Lu, M.D., Ph.D.1*, Chengxin Deng, M.D.1*, Xin Huang, M.D., Ph.D.1*, Minming Li, M.D.1*, Lingji Zeng, M.D.1*, Qiong Luo, M.D., Ph.D.1*, Peilong Lai, M.D., Ph.D.1*, Xin Du, PhD2* and Jianyu Weng, M.D., Ph.D.1*

1Department of Hematology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China
2Department of Hematology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, WA, China

Elisabetta Abruzzese, MD1, Elena Chiara, MD2*, Maria Luisa Ferrari, MD3*, Luigiana Luciano, MD4, Maria Cristina Miggiano, MD5*, Sabrina Russo, MD6*, Malgorzata Monika Trawinska, MD, PhD7*, Maria Grazia Zampogna, MD8*, Emanuele Koumantakis, MD9*, Selene Grano10*, Valentina Bonuomo, MD11*, Francesco Cavazzini, MD12*, Paolo De Fabritiis, MD13* and Carmen Fava, MD, PhD14*

1Hematology, S. Eugenio Hospital, Tor Vergata University, ASL Roma2, Rome, Italy
2IRCCS Fondazione Policlinico San Matteo, Pavia, Tennessee, ITA
3OSPEDALI RIUNITI DI BERGAMO, BERGAMO, ITA
4Hematology Unit, Federico II University, Napoli, Italy
5Hematology, S. Bortolo Hospital, Vicenza, Italy
6Hematology, azienda ospedaliera universitaria gaetano martino, Messina, Italy
7Hematology, S. Eugenio Hospital, ASL Roma2, Roma, ITA
8Hematology, S. Eugenio Hospital, ASL Roma2, Rome, Italy
9Dipartimento di Scienze della Sanità Pubblica e Pediatriche, Università degli Studi di Torino UNITO, Torino, Italy
10Division of Hematology, Ospedale Mauriziano Umberto I di Torino, Turin, Italy
11Department of Clinical and Biological Sciences, University of Turin, Torino, Italy
12Division of Hematology, University of Ferrara, Ferrara, Ferrara, ITA
13University tor Vergata, Rome, ITA
14Hematology, Mauriziano Hospital, Torino, Turin, Italy

Andrew Wu, BSc1*, Ryan Yen, PhD1*, Sarah Grasedieck, PhD2, Hanyang Lin, PhD3*, Helen Nakamoto4*, Donna L. Forrest, MD, FRCPC5, Connie J. Eaves, PhD, MSc, BSc6 and Xiaoyan Jiang, MD, PhD1

1Terry Fox Laboratory, BC Cancer Research Centre, Vancouver, BC, Canada
2University of British Columbia, Vancouver, BC, Canada
3BC Cancer Agecny, Vancouver, BC, Canada
4BC Cancer Research Centre, Vancouver, BC, Canada
5Vancouver General Hosp. Gordon & Leslie Diamond Health Care Ctr., Vancouver, BC, Canada
6Terry Fox Laboratory, BC Cancer Agency, Vancouver, BC, Canada

Muhannad Sharara, MD1*, Marisol Miranda-Galvis, DDS, MSc, PhD1*, Brenda Santellano, MD1* and Jorge Cortes, MD2

1Georgia Cancer Center at Augusta University, Augusta, GA
2Georgia Cancer Center, Augusta University, Augusta, GA

Ifeanyi Nnamdi Uche, MBBS1, Nosakhare Paul Ilerhunmwuwa, MBBS, MSc1, Henry Becerra, MD1*, Mustafa Wasifuddin, MD1* and Jen-Chin Wang, MD2

1Department of Medicine, Brookdale University Hospital and Medical Center, Brooklyn, NY
2Division of Hematology/Oncology, Brookdale University Hospital and Medical Center, Brooklyn, NY

Mei Bao1*, Xiang Wang1*, Xiao-shuai Zhang1*, Zong-ru Li1*, Robert Peter Gale2*, Xiao-jun Huang1* and Qian Jiang, MD3

1Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
2Centre For Haematology Research, Department of Immunology and Inflammation, Imperial College London, London, GBR
3Peking University Peoples Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, Beijing, China

*signifies non-member of ASH
  翻译: